OKYO.L
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Industry
Biotechnology
IPO Date
2018-07-17
Stock Exchange
LSE
Ticker
OKYO.L
According to OKYO Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 70.28M. This represents a change of 118.52% compared to the average of 32.16M of the last 4 quarters.
The mean historical Enterprise Value of OKYO Pharma Limited over the last ten years is 32.46M. The current 70.28M Enterprise Value has changed 21.55% with respect to the historical average. Over the past ten years (40 quarters), OKYO.L's Enterprise Value was at its highest in in the October 2022 quarter at 56.21M. The Enterprise Value was at its lowest in in the March 2010 quarter at -26640042.00.
Average
32.46M
Median
31.82M
Minimum
12.11M
Maximum
51.83M
Discovering the peaks and valleys of OKYO Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 75.35%
Maximum Annual Enterprise Value = 51.83M
Minimum Annual Increase = -31.39%
Minimum Annual Enterprise Value = 12.11M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 48.59M | 14.85% |
| 2024 | 42.31M | 18.97% |
| 2023 | 35.56M | -31.39% |
| 2022 | 51.83M | 68.96% |
| 2021 | 30.68M | -6.93% |
| 2020 | 32.96M | 17.75% |
| 2019 | 27.99M | 31.28% |
| 2018 | 21.32M | 0.44% |
| 2017 | 21.23M | 75.35% |
| 2016 | 12.11M | -25.33% |
The current Enterprise Value of OKYO Pharma Limited (OKYO.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
42.15M
5-year avg
41.79M
10-year avg
32.46M
OKYO Pharma Limited’s Enterprise Value is greater than Midatech Pharma plc (-1192952.21), greater than C4X Discovery Holdings plc (26.47M), greater than Synairgen plc (1.06M), greater than NetScientific plc (16.55M), greater than BiVictriX Therapeutics Plc (5.24M), greater than Yourgene Health Plc (27.05M), greater than Theracryf Plc (2.40M), greater than Destiny Pharma plc (-3509485.00), greater than Oxford Cannabinoid Technologies Holdings Plc (-1045660.00), greater than ReNeuron Group plc (-5684826.72),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -1192952.21 | N/A | |
| 26.47M | N/A | |
| 1.06M | N/A | |
| 16.55M | N/A | |
| 5.24M | N/A | |
| 27.05M | N/A | |
| 2.40M | N/A | |
| -3509485.00 | N/A | |
| -1045660.00 | N/A | |
| -5684826.72 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OKYO Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OKYO Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is OKYO Pharma Limited's Enterprise Value?
What is the highest Enterprise Value for OKYO Pharma Limited (OKYO.L)?
What is the 3-year average Enterprise Value for OKYO Pharma Limited (OKYO.L)?
What is the 5-year average Enterprise Value for OKYO Pharma Limited (OKYO.L)?
How does the current Enterprise Value for OKYO Pharma Limited (OKYO.L) compare to its historical average?